Toronto, Ontario–(Newsfile Corp. – November 30, 2023) – Sensor Technologies Corp. (CSE: SENS) (the “Company” or “Sensor”) is pleased to announce that, further to its press releases of June 30, 2023, the Company has received conditional approval from the Canadian Securities Exchange (“CSE”) with respect to the Company’s proposed change of business from a technology issuer to an investment issuer.
Final approval for the proposed change of business is conditional on the Company fulfilling the following conditions, among others:
the successful completion of the private placement for aggregate proceeds $500,000;
the completion of proposed debt conversions;
the completion of the Company’s investment in each of Robotic StemCell BioTech Ltd., Blockchain Assets Management Group Limited and 14125339 Canada Inc. (as described in the Company’s press release of January 19, 2023); and
the completion of any and all outstanding CSE application documentation and payment of applicable fees.
The Company intends to fulfill all of the conditions as soon as possible.
Corporation contact:
Philip Wong, Chief Executive Officer
email: ssphilipwong@gmail.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/189196
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…
Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…
NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…
SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…
LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…
ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…